What is life sciences real estate? Life sciences real estate is purpose-built lab, research and development, and good manufacturing practice space leased to biotech, pharmaceutical, and medical research tenants, and it underwrites nothing like a standard office or industrial building. AI life sciences real estate underwriting is the use of tools like Claude, ChatGPT, and Perplexity to analyze the three risks that actually drive these deals: the specialized physical plant, the credit and cash runway of venture-funded tenants, and the cost and downtime of re-tenanting highly specialized space. Because a wet lab can cost several hundred dollars per square foot to build and can sit empty for a year between tenants, small underwriting errors compound quickly. For the wider toolkit, see our guide to AI tools for commercial real estate investors.
Key Takeaways
- Life sciences real estate is specialized lab and R&D space with high HVAC, power, and structural requirements that make it far more expensive to build and re-tenant than office.
- The dominant credit question is tenant cash runway, since many biotech tenants are pre-revenue and funded by venture capital rather than by operating profit.
- AI underwrites these deals by reading the lease and tenant financials, modeling tenant improvement amortization, and stress testing downtime between specialized tenants.
- Lab rents and tenant improvement allowances run well above office norms, so the true return depends on net effective rent after amortizing a large buildout, not headline rent.
- Cluster markets like Boston, the San Francisco Bay Area, and San Diego concentrate demand, so submarket and building specifications matter more than in commodity property types.
Why Life Sciences Real Estate Underwrites Differently
Life sciences real estate underwrites differently because the building itself is a specialized instrument, not a neutral box. A wet lab typically needs higher floor-to-floor heights, far greater air changes per hour with dedicated exhaust, redundant power and backup generators, vibration isolation, chemical storage, and enhanced structural loading. These systems mean construction and conversion costs that dwarf standard office, and they mean a building that is lab-ready commands a very different value than a shell that merely could become a lab someday.
That specialization cuts both ways. Purpose-built lab space in a strong cluster can achieve premium rents and sticky tenancy, because tenants who invest millions in their fit-out do not move casually. But when a tenant does leave, the space can be slow and costly to re-lease, and a generic industrial or office user cannot simply move in. This is closer to underwriting a specialized asset like cold storage than a multi-tenant office, which is why our work on cold storage real estate and on small-bay flex industrial shares the same core lesson: physical specifications are underwriting inputs, not footnotes.
The Tenant Credit Problem: Underwriting Cash Runway
In life sciences, the single most important credit metric is often not a credit rating but the tenant's cash runway, meaning how many months the company can operate before it must raise more capital. Many lab tenants are pre-revenue biotechs burning venture funding to reach a clinical milestone. If the science stalls or the funding market tightens, the tenant can go dark long before the lease term ends, no matter how strong the space looks on paper.
AI is genuinely useful here. For a public tenant, ask Claude or Perplexity to pull the most recent quarterly filing and estimate cash on hand divided by quarterly burn to approximate the runway in months, then compare that runway to the remaining lease term. For a private tenant, the model can organize what is knowable, such as the last funding round, lead investors, and pipeline stage, and flag where the picture is thin. A large pharmaceutical anchor or a diversified research institution is a different animal, closer to a traditional credit tenant, and the underwriting should say so explicitly. Blending a pre-revenue startup and an investment-grade pharma into one weighted average lease term hides the real risk. For a framework on scoring tenant and lease income more broadly, our guide to net lease NNN investing pairs well with this analysis.
Modeling Tenant Improvements and Net Effective Rent
The economics of a life sciences deal live or die on tenant improvement amortization, because a lab buildout can cost several times an office buildout and must be recovered over the lease. Headline rent is misleading on its own. What matters is net effective rent, the rent that remains after you spread the tenant improvement allowance, leasing commissions, and free rent across the lease term and discount them appropriately.
Ask the AI to build the net effective rent bridge: start with the face rent, subtract the amortized tenant improvement allowance per square foot per year, subtract free rent and commissions, and show the result against your required return. Then have it test the scenario that defines this asset class, a tenant departure that leaves you carrying a specialized shell. Model the re-tenanting downtime, the cost to refresh or reconfigure the lab, and the concessions needed to attract the next tenant. When you run those numbers honestly, a headline cap rate that looked attractive can compress once you account for the buildout you will eventually eat. This is the same NOI-first discipline behind all sound CRE analysis; the difference is the size of the tenant improvement line. If you want help wiring this into a repeatable model, The AI Consulting Network works with investors on exactly these specialized underwriting workflows.
Submarket and Building Specification Analysis with AI
Location analysis in life sciences means cluster analysis, because demand concentrates in a handful of ecosystems where talent, capital, and research institutions cluster together. Boston and Cambridge, the San Francisco Bay Area including South San Francisco, and San Diego anchor the United States market, with additional activity in markets like the Research Triangle and Seattle. A lab building's value is tightly linked to its position within one of these ecosystems and to the depth of nearby demand.
Use AI to structure the market read rather than to invent it. Ask Claude to assemble a submarket brief covering recent leasing, sublease availability, and the pipeline of new supply, then have it cross-check the narrative against published research from firms such as JLL and CBRE, both of which produce dedicated life sciences market reports. On the building itself, feed the AI the specifications and ask it to grade the property against true lab-ready criteria: floor-to-floor height, air handling, power density, generator capacity, and vibration control. A building that shows well but lacks the systems to support wet lab use should be underwritten as convertible space with a conversion budget, not as turnkey lab. For a broader view of how AI handles specialized industrial and research property, our overview of AI for industrial and logistics real estate is a useful companion. For hands-on implementation support, CRE investors can reach out to Avi Hacker, J.D. at The AI Consulting Network.
Frequently Asked Questions
Q: What makes life sciences real estate riskier than standard office?
A: Two things: the building and the tenant. Lab space costs far more to build and is slow and expensive to re-tenant because a generic user cannot occupy it, and many tenants are pre-revenue biotechs whose survival depends on continued venture funding. Together these mean higher potential downtime and higher re-leasing cost than a comparable office asset.
Q: How does AI assess a biotech tenant's ability to pay rent?
A: For public tenants, AI can pull recent financial filings and estimate cash runway by dividing cash on hand by the quarterly burn rate, then compare that runway to the remaining lease term. For private tenants, it can organize funding history, investors, and pipeline stage to frame the risk. This runway view is more predictive than a static credit label for early-stage life sciences tenants.
Q: Why is net effective rent so important in life sciences deals?
A: Because tenant improvement allowances for lab space are large, sometimes several hundred dollars per square foot, the face rent overstates what you actually earn. Net effective rent spreads those buildout costs, commissions, and free rent across the term, revealing the real return. A deal can look strong on headline rent and thin once the buildout is amortized.
Q: Which markets should investors focus on for life sciences real estate?
A: Demand concentrates in established clusters, principally Boston and Cambridge, the San Francisco Bay Area, and San Diego, with growing activity in markets like the Research Triangle and Seattle. Because the asset class depends on nearby research talent and capital, submarket position within a cluster is a central underwriting factor rather than a secondary one.